A61M 1/3689
By biological cells
Official title: {by biological cells}
A61M1/3689 (By biological cells) appears on 63 US grants and 97 published applications in this corpus.
Search patents in A61M- Granted patents
- 63
- Published applications
- 97
- Assignees
- 55
- Inventors
- 156
- Latest grant
- 25 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 1 |
| 2002 | 0 | 1 |
| 2003 | 1 | 2 |
| 2004 | 0 | 0 |
| 2005 | 1 | 3 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 2 |
| 2009 | 0 | 3 |
| 2010 | 1 | 6 |
| 2011 | 2 | 7 |
| 2012 | 4 | 8 |
| 2013 | 3 | 5 |
| 2014 | 4 | 3 |
| 2015 | 1 | 4 |
| 2016 | 5 | 7 |
| 2017 | 1 | 2 |
| 2018 | 1 | 4 |
| 2019 | 2 | 5 |
| 2020 | 3 | 6 |
| 2021 | 4 | 4 |
| 2022 | 4 | 7 |
| 2023 | 3 | 3 |
| 2024 | 7 | 6 |
| 2025 | 5 | 3 |
| 2026 | 0 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Extracorporeal bioengineered dual-cell liver regeneration system (EBDLR) and bio purifier therefor25 Nov 2025US 12,478,723 B2Ykrita Lifesciences Private Limited
- Processing blood21 Oct 2025US 12,447,253 B2Therakos Development Limited
- Flow cell5 Aug 2025US 12,377,201 B2Terumo BCT Biotechnologies, LLC
- Combined bio-artificial liver support system27 May 2025US 12,311,097 B2Southern Medical University Zhujiang Hospital
- Therapeutic intervention methods, devices, and systems1 Apr 2025US 12,266,439 B2The Regents of the University of California
- Recombinant Viral Particle for Gene and/or Cellular Therapy5 Mar 2026US 2026/0060984 A1Innovative Cellular Therapeutics Holdings, Ltd.
- Extracorporeal bioengineered dual-cell liver regeneration system (ebdlr) and bio purifier therefor19 Feb 2026US 2026/0048190 A1
- Method of treating subjects with acute liver failure using extracorporeal bioengineered dual-cell liver regeneration system19 Feb 2026US 2026/0048191 A1
- Processing blood29 Jan 2026US 2026/0027278 A1Therakos Development Limited
- Therapeutic intervention methods, devices, and systems14 Aug 2025US 2025/0259731 A1The Regents of the University of California
Most cited
By later US patents
- Method and apparatus for therapeutically treating immunological disorders and disease states75US 5,026,365 AUniversity of Massachusetts · 1991
- Bioreactor with application as blood therapy device70US 6,582,955 B2Spectrum Laboratories, Inc. · 2003
- Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo50US 6,150,164 AThe Regents of the University of Michigan · 2000
- Systems, methods, and devices relating to a cellularized nephron unit37US 7,790,028 B1The Charles Stark Draper Laboratory, Inc. · 2010
- Liver assist device employing transformed cell lines31US 4,853,324 A1989